Gene tests could guide cancer patients to best trials
NCT ID NCT02806388
First seen May 14, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study looks at the genetic makeup of solid tumors in 5,500 cancer patients to help doctors choose the most suitable treatments and clinical trials. Participants provide a tumor sample for molecular profiling. The goal is to learn how genetic changes relate to treatment outcomes and improve trial matching.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Cancer Centre, Singapore
RECRUITINGSingapore, Singapore
Conditions
Explore the condition pages connected to this study.